Literature DB >> 30789787

Physiology and Predictors of Impaired Gas Exchange in Infants with Bronchopulmonary Dysplasia.

Jenny Svedenkrans1,2,3, Benjamin Stoecklin1,4,5, J Gareth Jones6, Dorota A Doherty7, J Jane Pillow1,4.   

Abstract

Rationale: A sensitive outcome measure for infants with bronchopulmonary dysplasia would facilitate clinical benchmarking and enhance epidemiologic understanding, evaluation of clinical interventions, and outcome prediction.
Objectives: Noninvasive assessment of pulmonary gas exchange in preterm infants with and without bronchopulmonary dysplasia to grade disease severity and to identify determinants of impaired gas exchange.
Methods: This is a prospective observational study in very preterm infants. Inspired oxygen partial pressure (PiO2) was decreased stepwise to achieve oxygen saturation as measured by pulse oximetry (SpO2) that decreased from 95% to 86%. Right shift, V⋅a/Q⋅, and right-left shunt were derived from the resulting SpO2 versus PiO2 curve and compared with current disease severity classification. Potential determinants of shift, V⋅a/Q⋅, and shunt were identified using principal components analysis and multiple linear regression.Measurements and Main
Results: A total of 219 infants with median (interquartile range) gestation of 28 weeks and 0 days (26 weeks and 0 days to 29 weeks and 0 days) had a valid study at 35 weeks and 4 days (34 weeks and 1 day to 39 weeks and 3 days) of postmenstrual age. Shift increased and V⋅a/Q⋅ decreased as severity of bronchopulmonary dysplasia increased. Infants with moderate-severe disease also had increased shunt. Extent of impaired gas exchange overlapped between severity groups. Infants requiring mechanical support but no supplemental oxygen at 36 weeks' postmenstrual age had similar values of shift, V⋅a/Q⋅, and shunt to preterm infants without bronchopulmonary dysplasia. Lower gestation and increased duration of invasive ventilation independently predicted increased shift, decreased V⋅a/Q⋅, and increased shunt. Shift was the most sensitive and specific index of the severity of bronchopulmonary dysplasia.Conclusions: Most infants with bronchopulmonary dysplasia have impaired oxygenation quantified by a simple, sensitive bedside test. Shift of the SpO2/PiO2 curve may be useful for prediction and measurement of preterm infant respiratory outcomes.

Entities:  

Mesh:

Year:  2019        PMID: 30789787     DOI: 10.1164/rccm.201810-2037OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  5 in total

Review 1.  Bronchopulmonary dysplasia.

Authors:  Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe
Journal:  Nat Rev Dis Primers       Date:  2019-11-14       Impact factor: 52.329

2.  Pulmonary hypertension in a neonatologist-performed echocardiographic follow-up of bronchopulmonary dysplasia.

Authors:  Marilena Savoia; Francesca Rech Morassutti; Luigi Castriotta; Daisy Pavoni; Peter M Mourani; Paola Freschi; Luigi Cattarossi; Antonio Tonutti
Journal:  Eur J Pediatr       Date:  2021-01-21       Impact factor: 3.183

3.  Inhaled Nitric Oxide Use and Outcomes in Critically Ill Children With a History of Prematurity.

Authors:  Aline B Maddux; Peter M Mourani; Russell Banks; Ron W Reeder; Murray M Pollack; Robert A Berg; Kathleen L Meert; Patrick S McQuillen; Andrew R Yates; Daniel A Notterman; John T Berger
Journal:  Respir Care       Date:  2021-10       Impact factor: 2.339

4.  What is BPD today and in the next 50 years?

Authors:  Richard J Martin; Alan H Jobe; Eduardo Bancalari
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-10-13       Impact factor: 6.011

5.  The relationship between ventilatory ratio (VR) and 28-day hospital mortality by restricted cubic splines (RCS) in 14,328 mechanically ventilated ICU patients.

Authors:  Yingying Yang; Yi Chi; Siyi Yuan; Qing Zhang; Longxiang Su; Yun Long; Huaiwu He
Journal:  BMC Pulm Med       Date:  2022-06-13       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.